🇺🇸 Triamcort in United States
21 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 21
Most-reported reactions
- Epicondylitis — 3 reports (14.29%)
- Abdominal Distension — 2 reports (9.52%)
- Asthenia — 2 reports (9.52%)
- Asthma — 2 reports (9.52%)
- Drug Interaction — 2 reports (9.52%)
- Dyspnoea — 2 reports (9.52%)
- Erythema — 2 reports (9.52%)
- General Physical Health Deterioration — 2 reports (9.52%)
- Osteoarthritis — 2 reports (9.52%)
- Pulmonary Embolism — 2 reports (9.52%)
Other Other approved in United States
Frequently asked questions
Is Triamcort approved in United States?
Triamcort does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Triamcort in United States?
Balgrist University Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.